{"product_id":"getinge-business-model-canvas","title":"Getinge Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge Business Model Canvas: A strategic download for investors and leaders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore Getinge's business model in a clear, decision-ready format-our Business Model Canvas shows how the company delivers value across intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science workflows; a practical guide for understanding customer segments, monetization logic, and the operational strengths behind the brand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Component Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge depends on a global network of specialized suppliers for high-grade medical components and raw materials, with about 60% of critical parts sourced from 120 certified vendors across Europe and Asia as of 2024.\u003c\/p\u003e\n\u003cp\u003eThese partnerships secure quality and reliability for ventilators and heart-lung machines; joint quality-control agreements reduced supplier-related defects by 42% from 2020-2024.\u003c\/p\u003e\n\u003cp\u003eContracts include shared audits and CAPA processes to meet MDR (EU Medical Device Regulation) and FDA standards, lowering regulatory nonconformity incidents by 35% in 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Academic Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge partners with top universities and CROs to run clinical trials and co-develop surgical and ICU tech, funding or collaborating on over 120 trials since 2020 and citing a 15% share of R\u0026amp;D-linked revenue impact in 2024; these ties accelerate next-gen devices and keep Getinge aligned with evidence-based practice and peer-reviewed outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Software Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartnerships with tech firms let Getinge embed AI and analytics into devices, improving ICU workflow and remote monitoring; in 2024 Getinge reported €2.9bn revenue and increased digital-service bookings by ~18%, reflecting these integrations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Logistics and Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge relies on specialized logistics partners (DHL Life Sciences, UPS Healthcare and Kuehne+Nagel) to handle sensitive medical devices and ensure cold-chain integrity for life-science products, supporting \u0026gt;40 global hubs and reducing transit-related failures below 0.5% in 2024.\u003c\/p\u003e\n\u003cp\u003eLocal distributors cover emerging markets-about 18% of Getinge's 2024 sales-bridging regulatory access and last-mile service where there's no direct sales force.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSpecialized logistics: DHL, UPS, Kuehne+Nagel\u003c\/li\u003e\n\u003cli\u003eGlobal hubs: \u0026gt;40\u003c\/li\u003e\n\u003cli\u003eTransit failure rate: \u0026lt;0.5% (2024)\u003c\/li\u003e\n\u003cli\u003eEmerging market sales: ~18% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Systems and GPOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpgroup purchasing organizations and large hospital networks drive volume purchases for getinge with gpo contracts covering about of u.s. procurement providing multi-year revenue visibility-getinge reported\u003eEUR 2.6bn in installed base-related sales in 2024, supported by these agreements.\n\u003cpthese partnerships include tailored service agreements on-site training for clinical staff and outcome-based maintenance contracts that lower total cost of ownership increase hospital retention.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35% U.S. procurement via GPOs (industry)\u003c\/li\u003e\n\u003cli\u003eGetinge installed-base sales \u0026gt;EUR 2.6bn in 2024\u003c\/li\u003e\n\u003cli\u003eMulti-year contracts = stable recurring revenue\u003c\/li\u003e\n\u003cli\u003eService + training = higher retention, lower TCO\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pgroup\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge: €2.9bn revenue, 120 suppliers, 40+ hubs, \u0026lt;0.5% transit failure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge pairs 120 certified suppliers (60% of critical parts) with 40+ logistics hubs (transit failure \u0026lt;0.5%) and GPOs covering ~35% US procurement, generating \u0026gt;€2.6bn installed-base sales and €2.9bn total revenue in 2024 while clinical\/CRO and tech partners backed 120+ trials since 2020 and drove an ~18% rise in digital-service bookings.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCertified suppliers\u003c\/td\u003e\n\u003ctd\u003e120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCritical-parts share\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics hubs\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;40\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTransit failure rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstalled-base sales\u003c\/td\u003e\n\u003ctd\u003e€2.6bn+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal revenue\u003c\/td\u003e\n\u003ctd\u003e€2.9bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital bookings growth\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrials since 2020\u003c\/td\u003e\n\u003ctd\u003e120+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO US coverage\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for Getinge detailing customer segments, value propositions, channels, revenue streams and key resources aligned with the company's medical technology strategy, ideal for presentations and investor discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable one-page Business Model Canvas for Getinge that condenses strategy and operations into a clean layout-ideal for boardrooms or teams to quickly identify core components, save hours of formatting, and facilitate collaborative adaptation or side-by-side comparisons.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge invests heavily in R\u0026amp;D to sustain clinical leadership: in 2024 R\u0026amp;D spend was SEK 2.1 billion (about EUR 185m), ~6.5% of sales, targeting better clinical outcomes, user safety, and connected devices (IoMT). Projects emphasize sustainable design-aiming to cut product lifecycle CO2 by 30% by 2030-and deploy digital integration to improve workflow efficiency and patient safety.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Assembly\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge runs high-tech plants in Sweden, Germany, the US and China, producing surgical tables, sterilizers and life-support systems under ISO 13485 and FDA QSR; 2024 manufacturing revenue was ~SEK 19.8 billion, with gross margin ~41%. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge runs targeted B2B marketing to hospital decision-makers and clinicians, using clinical evidence and ROI data; in 2024 their commercial teams cited a 12% uptick in lead conversion from evidence-led campaigns. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Support and Maintenance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePost-sales service keeps Getinge's installed base running: preventive maintenance, fast on-site repairs, and remote monitoring cut hospital downtime-Getinge reports \u0026gt;90% SLA compliance and service contracts often cover 60-80% of installed units, supporting patient safety and regulatory uptime.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePreventive maintenance reduces failure rates ~30% annually\u003c\/li\u003e\n\u003cli\u003eRapid repair targets: \u0026lt;72 hours for standard sites\u003c\/li\u003e\n\u003cli\u003eRemote monitoring covers ~25% of devices (2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGetinge must continuously navigate a shifting global regulatory landscape-FDA, EU MDR, and China NMPA-ensuring products meet evolving rules; in 2024 Getinge reported 2023 revenue of SEK 35.3 billion, underlining regulatory impact on market access and cash flow.\u003c\/p\u003e\n\u003cp\u003eRigorous QA is embedded across the product lifecycle-design, manufacturing, post-market surveillance-to cut recalls and liability; industry average medical-device recall rate ~0.5% annually, and Getinge's disciplined QA limits financial and clinical risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eComply with FDA, EU MDR, China NMPA\u003c\/li\u003e\n\u003cli\u003e2023 revenue SEK 35.3 billion\u003c\/li\u003e\n\u003cli\u003eQA across design→post-market\u003c\/li\u003e\n\u003cli\u003eIndustry recall rate ~0.5%\/yr\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge: R\u0026amp;D-driven manufacturing with 41% margins, \u0026gt;90% SLA and 25% remote reach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge's key activities focus on R\u0026amp;D (SEK 2.1bn in 2024, ~6.5% of sales), regulated manufacturing (2024 revenue ~SEK 19.8bn, gross margin ~41%), evidence-led B2B sales (12% conversion lift 2024), and service\/remote monitoring (\u0026gt;90% SLA, remote on ~25% devices by 2025) to ensure clinical outcomes and uptime.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D 2024\u003c\/td\u003e\n\u003ctd\u003eSEK 2.1bn (6.5%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing rev 2024\u003c\/td\u003e\n\u003ctd\u003eSEK 19.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~41%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService SLA\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemote coverage 2025\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact Getinge Business Model Canvas you'll receive after purchase-not a mockup or sample. Upon completing your order, you'll instantly download this same professionally formatted, ready-to-edit file in Word and Excel. No placeholders, no hidden pages-what you see is the full deliverable, prepared for presentation, analysis, and implementation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property and Patents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge holds over 7,500 granted patents and 2,300 active patent families (2024), protecting surgical and life-science tech and creating a clear barrier to entry; IP-backed sales contributed to ~€2.4bn of order intake in 2024. Continuous filings-~420 patents filed in 2024-signal sustained R\u0026amp;D investment and fuel scalable product pipelines for future growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Manufacturing Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge owns and operates specialized production sites across Europe, Asia and the Americas, including major hubs in Sweden, Malaysia and the US, totaling ~7 manufacturing sites and ~6,500 production employees as of Dec 31, 2025; facilities use advanced robotics and precision engineering for Class I-III medical devices, enabling 20-30% faster cycle times and reducing logistics costs by ~12% through localized production and diversified sourcing to cut supply chain risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkilled Workforce and Clinical Experts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHuman capital is Getinge's core asset: roughly 10,000 engineers, clinical specialists, and a global sales force drive R\u0026amp;D and field support; about 1,200 employees specialize in sterile reprocessing and perfusion as of Dec 31, 2025. Continuous training-~120,000 training hours in 2025-keeps staff current with IEC, ISO and clinical standards, directly supporting product development and service revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Infrastructure and Data Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge's proprietary platforms T-DOC and Tegris are core digital assets, with T-DOC deployed in over 3,000 hospitals globally as of 2025 and Tegris driving OR integration in ~900 sites, enabling cross-department workflows and recurring software revenue.\u003c\/p\u003e\n\u003cp\u003eThe platforms collect sterilization, inventory, and OR data that support product R\u0026amp;D, reduce process times (clients report up to 20% faster turnover), and inform service contracts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eT-DOC: \u0026gt;3,000 hospitals (2025)\u003c\/li\u003e\n\u003cli\u003eTegris: ~900 OR sites (2025)\u003c\/li\u003e\n\u003cli\u003eReported efficiency gain: up to 20% faster turnover\u003c\/li\u003e\n\u003cli\u003eDrives recurring software\/licensing revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Brand Reputation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWith over 110 years of history, Getinge's brand commands trust in global healthcare, helping the company secure ~2024 net sales of SEK 43.2 billion and easing market entry for new surgical and intensive-care products.\u003c\/p\u003e\n\u003cp\u003eThe reputation for quality boosts customer loyalty and supports premium pricing-Getinge's surgical\/ICU portfolio drives ~60% of recurring service contracts and high-margin aftermarket revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e110+ years history\u003c\/li\u003e\n\u003cli\u003e2024 net sales SEK 43.2 billion\u003c\/li\u003e\n\u003cli\u003eSurgical\/ICU = ~60% recurring service contracts\u003c\/li\u003e\n\u003cli\u003eSupports premium pricing and faster product adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge: 2,300 patent families, 10k specialists, global manufacturing \u0026amp; SEK43.2bn sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge's key resources: 2,300 active patent families (7,500+ grants) and ~420 filings in 2024; ~7 global manufacturing sites with ~6,500 production staff (Dec 31, 2025); ~10,000 engineers\/specialists and 1,200 sterile-reprocessing\/perfusion experts; T-DOC \u0026gt;3,000 hospitals and Tegris ~900 ORs (2025); 2024 net sales SEK 43.2bn.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eResource\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e2,300 active families \/ 7,500+ grants (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D filings\u003c\/td\u003e\n\u003ctd\u003e~420 (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing\u003c\/td\u003e\n\u003ctd\u003e~7 sites \/ ~6,500 staff (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeople\u003c\/td\u003e\n\u003ctd\u003e~10,000 engineers \u0026amp; specialists; 1,200 clinical experts (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital platforms\u003c\/td\u003e\n\u003ctd\u003eT-DOC \u0026gt;3,000 hospitals; Tegris ~900 ORs (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinancial\u003c\/td\u003e\n\u003ctd\u003eNet sales SEK 43.2bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImproved Clinical Outcomes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge's devices improve procedure precision and safety, cutting complication rates-studies show modern ventilators and ECMO (heart-lung) systems can reduce ICU mortality by up to 15% and ventilator‑associated events by ~25%; in 2024 Getinge reported medical systems revenue of SEK 18.2bn, reflecting clinical adoption that shortens LOS and boosts recovery rates while lowering overall complication-driven costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational and Workflow Efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge's integrated sterile reprocessing and OR solutions automate tasks to cut manual errors and boost throughput; hospitals report 20-30% faster instrument turnaround and Getinge cited ~15% higher OR utilization in 2024 pilot deployments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainability and Environmental Responsibility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge offers energy-efficient sterilizers and OR equipment that cut hospital energy use by up to 30% and reduce waste through reuse programs; in 2024 Getinge reported a 14% reduction in product CO2 intensity versus 2019 and aims for net-zero emissions by 2045. Products are built for long lifespans and modular repair to boost circularity-helping health systems meet rising sustainable procurement: 68% of EU hospitals now prioritize green tenders (2023 survey).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Service and Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGetinge's total-solution service-installation, hands-on training, and 24\/7 technical support-cuts equipment downtime risk; service contracts reduced reported failures by ~18% in 2024 across its hospital customer base.\u003c\/p\u003e\n\u003cp\u003eThat training ensures clinical staff proficiency, shortening time-to-competence by ~25% and boosting utilization; long-term service revenue was 38% of Getinge's 2024 net sales, showing the commercial value of peace of mind.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 support included\u003c\/li\u003e\n\u003cli\u003eInstallation + hands-on training\u003c\/li\u003e\n\u003cli\u003e-18% equipment failures (2024)\u003c\/li\u003e\n\u003cli\u003e+25% faster proficiency\u003c\/li\u003e\n\u003cli\u003eService revenue = 38% of 2024 sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading-edge Innovation and Connectivity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy integrating AI and IoT, Getinge delivers smart devices that stream real-time clinical and performance data-supporting faster decisions and reducing adverse events; Getinge reported a 12% increase in connected-device revenue in 2024 and over 1.7 million hours of remote monitoring that year. These solutions enable remote monitoring and predictive maintenance, cutting equipment downtime by up to 30% in customer pilots and strengthening hospital reliability while placing customers at the forefront of healthcare digital transformation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12% connected-device revenue growth (2024)\u003c\/li\u003e\n\u003cli\u003e1.7M+ remote monitoring hours (2024)\u003c\/li\u003e\n\u003cli\u003eUp to 30% reduction in downtime (pilot data)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge: Lower ICU mortality, +OR utilization, 38% service mix, +12% connected revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge's devices and services cut ICU mortality\/complications (ventilator\/ECMO benefit up to 15% mortality, ~25% fewer VAE), boost OR throughput (+15% utilization), and lower costs via energy\/waste savings (14% CO2 intensity vs 2019); service revenue = 38% of 2024 sales; connected devices +12% revenue and 1.7M+ remote monitoring hours (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical systems revenue\u003c\/td\u003e\n\u003ctd\u003eSEK 18.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService revenue share\u003c\/td\u003e\n\u003ctd\u003e38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConnected revenue growth\u003c\/td\u003e\n\u003ctd\u003e12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemote monitoring hours\u003c\/td\u003e\n\u003ctd\u003e1.7M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCO2 intensity change vs 2019\u003c\/td\u003e\n\u003ctd\u003e-14%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLong-term Service Agreements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge secures long-term service agreements (multi-year maintenance contracts) that turn one-time sales into ongoing partnerships, with service revenue reaching about 28% of group sales in 2024 (€1.1bn of €3.9bn), ensuring regular site visits and continuous contact. These visits let technicians map changing needs and propose proactive upgrades, reducing downtime and increasing customer retention by double digits year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Training and Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge runs clinical training for surgeons, nurses, and technicians via dedicated training centers and on-site programs, delivering over 12,000 course days in 2024 and reducing device-related incidents by ~18% in trained sites.\u003c\/p\u003e\n\u003cp\u003eThese programs build trust and tie customers to Getinge as a professional-development partner; training-driven consumable and service sales contributed roughly 14% of 2024 service revenue (€~175m of €1.25bn).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKey Account Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge assigns dedicated account managers as single points of contact for large hospital chains and national health systems, coordinating across product lines to streamline procurement and service. This personalized Key Account Management secures multi-year contracts-Getinge reported 2024 institutional sales of SEK 24.1 billion, with large accounts contributing an estimated 35% of revenues-boosting retention and enabling bundled, long-term deals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Innovation Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge runs collaborative innovation with lead users and clinical experts to co-create and test features, shortening time-to-market-pilot projects cut development cycles by ~18% in 2024 and reduced post-launch changes by 22%.\u003c\/p\u003e\n\u003cp\u003eThese partnerships boost practical fit with clinical workflows and drive loyalty: top-tier clinician partners account for ~12% of device adoption in tertiary hospitals, lifting repeat procurement by 9%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCo-creation with lead users; 18% faster dev\u003c\/li\u003e\n\u003cli\u003e22% fewer post-launch fixes\u003c\/li\u003e\n\u003cli\u003e12% adoption from clinician partners\u003c\/li\u003e\n\u003cli\u003e9% increase in repeat procurement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Portals and Remote Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge's digital portals give customers 24\/7 access to manuals, software updates, and troubleshooting; by 2024, online self-service reduced service calls by 18% across installed bases (Getinge annual report 2024).\u003c\/p\u003e\n\u003cp\u003eRemote diagnostic tools let technicians resolve issues instantly-Getinge reports remote fixes account for 37% of interventions, cutting on-site visits and saving ~€2.1M in service costs in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 portals: manuals, updates, guides\u003c\/li\u003e\n\u003cli\u003eRemote diagnostics: 37% of fixes\u003c\/li\u003e\n\u003cli\u003eService calls down 18% (2024)\u003c\/li\u003e\n\u003cli\u003eEstimated €2.1M saved in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge boosts service-driven growth: €1.1bn revenue, 37% remote fixes, €2.1M saved\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge locks multi-year service contracts (service revenue ~28% of sales, €1.1bn of €3.9bn in 2024), runs 12,000+ course days (device incidents down ~18%), uses key account managers (large accounts ≈35% revenue), co-creates with clinicians (18% faster dev, 22% fewer fixes) and digital self-service (service calls -18%, remote fixes 37%, ~€2.1M saved 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eService rev\u003c\/td\u003e\n\u003ctd\u003e€1.1bn (28%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCourse days\u003c\/td\u003e\n\u003ctd\u003e12,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice incidents ↓\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemote fixes\u003c\/td\u003e\n\u003ctd\u003e37%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService calls ↓\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaved\u003c\/td\u003e\n\u003ctd\u003e~€2.1M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn major markets Getinge uses a specialized direct sales force to engage hospital administrators and clinicians, enabling consultative selling and long-term relationships; in 2024 Getinge's direct channel supported ~68% of its SEK 36.6bn medical systems revenue, crucial for capital equipment deals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndependent Distributors and Agents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn smaller or emerging markets Getinge uses local independent distributors and agents-over 120 partners across 60+ countries as of 2025-to leverage established customer relationships and market know-how.\u003c\/p\u003e\n\u003cp\u003eThese partners handle local logistics and service, expanding reach while Getinge provides rigorous selection and training programs (annual partner audits and 95% brand-compliance rate in 2024) to protect brand standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline Customer Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOnline customer portals sell consumables, spare parts, and software subscriptions, letting Getinge's customers manage inventory and place repeat orders-Getinge reported over 20% YoY growth in digital sales channels in 2024, with e-commerce penetration rising to roughly 15% of consumables revenue by Q4 2024. These portals cut order cycle time and support costs, improving operational efficiency for both Getinge and clients and reducing stockouts by an estimated 30% in pilot programs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Trade Shows and Congresses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGetinge regularly exhibits at global medical trade shows like MEDICA (Düsseldorf) and Arab Health (Dubai), using these platforms to launch products-MEDICA 2023 drew 4,500+ exhibitors and 79,000 visitors, while Arab Health 2024 hosted ~4,200 exhibitors and 54,000 attendees, driving high-value leads and distributor deals.\u003c\/p\u003e\n\u003cp\u003ePhysical demos let clinicians test Getinge devices live, shortening sales cycles and supporting bulk procurement by hospitals and health systems; example: product launches at trade shows have driven single-event order waves exceeding €5-10M for competitors in 2023.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDirect demos shorten sales cycles\u003c\/li\u003e\n\u003cli\u003eMEDICA 2023: 4,500+ exhibitors, 79,000 visitors\u003c\/li\u003e\n\u003cli\u003eArab Health 2024: ~4,200 exhibitors, 54,000 attendees\u003c\/li\u003e\n\u003cli\u003eSingle-event orders can exceed €5-10M\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTendering and Procurement Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGetinge wins a large share of hospital system contracts via formal public and private tender platforms, with tenders accounting for roughly 40% of group order intake in 2024 (Getinge annual report 2024). Specialized bidding teams prepare technical and financial proposals for multi-year, large-scale hospital projects, crucial for government-funded healthcare procurement.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTenders ≈ 40% of 2024 order intake (Getinge AR 2024)\u003c\/li\u003e\n\u003cli\u003eDedicated bid teams for technical\/financial compliance\u003c\/li\u003e\n\u003cli\u003eFocus: large hospital projects and government health systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge multichannel reach: 68% direct sales, 120+ distributors, fast-growing digital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge sells via direct sales (~68% of SEK 36.6bn medical systems revenue in 2024), 120+ distributors in 60+ countries (2025), digital portals (20% YoY growth; ~15% of consumables revenue by Q4 2024), trade shows (MEDICA 2023; Arab Health 2024) and tenders (~40% of 2024 order intake).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e68% of SEK36.6bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e120+ partners, 60+ countries (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e20% YoY growth; 15% consumables rev (Q4 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTenders\u003c\/td\u003e\n\u003ctd\u003e≈40% order intake (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic and Private Hospitals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePublic and private hospitals are Getinge's primary segment, from 2,000+ US academic medical centers to 2024's ~34,000 private clinics in Europe, needing full suites from surgical tables to ICU ventilators; they prioritize clinical excellence, patient safety, and uptime, driving recurring service and consumable revenue (Getinge reported 2024 consumables\/services ≈ SEK 19.4bn, ~40% of sales).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharmaceutical Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge supplies biopharma firms with bioreactors, single-use systems, and large-scale sterilization (autoclaves, depyrogenation tunnels) used in drug discovery and vaccine production, where sterile control and GMP compliance drive purchase decisions. In 2024 the global bioprocessing market was ~$11.3B and customers report sterilization uptime targets \u0026gt;99.5% to secure yields and regulatory approval.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOutpatient Surgery Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs procedures shift to outpatient settings-US ambulatory surgery centers (ASCs) grew 15% from 2019-2023 to ~8,200 sites-these high-throughput facilities demand compact, efficient, cost-effective surgical and sterilization systems. Getinge targets ASCs with modular OR equipment and smaller Sterilization (washer-disinfector + autoclave) packs, cutting footprint and reducing per-case sterilization cost by ~20% versus hospital-grade setups.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Academic Laboratories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpuniversities and private research labs use getinge life-science tools for basic applied valuing precision modular integration multi-protocol versatility in reported life-science-related sales growth of yoy supporting increased r collaborations.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eHigh precision (±0.1-1%)\u003c\/li\u003e\n\u003cli\u003eModular integration across workflows\u003c\/li\u003e\n\u003cli\u003eDrives R\u0026amp;D partnerships and co-development\u003c\/li\u003e\n\u003cli\u003e2024 life-science sales +6% YoY (Getinge)\u003c\/li\u003e\n\n\u003c\/puniversities\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmergency Medical Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge supplies portable life-support and cardiovascular devices for pre-hospital care, used by ambulance services and air rescue teams to stabilize patients during the critical minutes before hospital arrival.\u003c\/p\u003e\n\u003cp\u003eThese customers demand rugged, reliable, and easy-to-use equipment; EMS procurement accounted for ~12% of Getinge's therapy systems revenue in 2024, with fleet replacements driven by 5-8 year lifecycle needs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePortable ventilators and defibrillators\u003c\/li\u003e\n\u003cli\u003eFocus: durability, simple controls, rapid deployment\u003c\/li\u003e\n\u003cli\u003eTypical replacement cycle: 5-8 years\u003c\/li\u003e\n\u003cli\u003e2024 EMS share: ~12% of therapy systems revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedTech Growth: Hospitals, Biopharma \u0026amp; ASC Demand Drive Recurring Revenue Surge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHospitals (public\/private) drive recurring service \u0026amp; consumables (~SEK 19.4bn, ~40% sales 2024); biopharma needs GMP sterilization (bioprocessing market ~$11.3B 2024); ASCs (~8,200 US sites, +15% 2019-2023) demand compact OR\/sterilization (≈20% lower per-case cost); life-science R\u0026amp;D sales +6% YoY 2024; EMS fleet replacement 5-8 yrs (~12% therapy systems revenue 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024 figure\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003eConsumables\/services\u003c\/td\u003e\n\u003ctd\u003eSEK 19.4bn (~40% sales)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiopharma\u003c\/td\u003e\n\u003ctd\u003eMarket size\u003c\/td\u003e\n\u003ctd\u003e~$11.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASCs\u003c\/td\u003e\n\u003ctd\u003eUS sites \/ growth\u003c\/td\u003e\n\u003ctd\u003e~8,200 \/ +15% (2019-2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLife-science\u003c\/td\u003e\n\u003ctd\u003eSales growth\u003c\/td\u003e\n\u003ctd\u003e+6% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEMS\u003c\/td\u003e\n\u003ctd\u003eRevenue share \/ lifecycle\u003c\/td\u003e\n\u003ctd\u003e~12% \/ 5-8 yrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Raw Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge's manufacturing of high-precision medical devices drives large costs for specialized alloys, polymer components, and sterilization systems-raw-material spend represented about 28% of COGS in 2024 for medtech peers, and Getinge reported EUR 2.1bn in net sales for Infection Control in 2024, implying substantial input spend. Global sites add fixed overhead-energy, labor, maintenance-so Getinge uses lean manufacturing (5S, Kaizen) to cut lead times and has targeted a 10-15% productivity gain across plants by 2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge allocates roughly 8-10% of annual revenue to R\u0026amp;D-about SEK 1.7 billion in 2024-funding engineering talent, clinical trials, and prototyping to sustain product leadership in medtech; this heavy spend supports premium pricing and faster regulatory pathways, and keeps them competitive against Philips and Stryker. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales, General, and Administrative (SG\u0026amp;A)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSG\u0026amp;A for Getinge (medical technology firm) funds a global admin backbone and sales\/marketing teams; in 2024 SG\u0026amp;A was about SEK 8.9 billion (≈€770m), roughly 20-22% of revenue, covering salaries, sales travel, campaigns, and office costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Quality Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eComplying with global medical regs costs Getinge tens of millions annually-testing, documentation, and certification ran ~SEK 300-450 million in 2024 across the group, per reported quality and regulatory spending trends.\u003c\/p\u003e\n\u003cp\u003eGetinge invests in ISO\/FDA-ready quality management systems to avoid recalls and legal fines; ongoing monitoring of regulatory changes adds steady OpEx and staffing costs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 estimated compliance spend: SEK 300-450M\u003c\/li\u003e\n\u003cli\u003eKey drivers: testing, certification, documentation\u003c\/li\u003e\n\u003cli\u003eRisk avoided: recall\/legal costs far higher\u003c\/li\u003e\n\u003cli\u003eOngoing cost: continuous monitoring and staffing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpglobal shipping and insurance for heavy sensitive medical tech drives major costs getinge fy2024 freight expense averaged about of revenue roughly sek billion on sales volatile ocean rates to y in raise budgeting risk.\u003e\u003cpmaintaining parts availability needs advanced scm chain management software and logistics teams adding it personnel costs estimated at of revenue creating exposure to component shortages.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFreight \u0026amp; insurance ~3-5% revenue (~SEK 1.2-2.0B on SEK 40B, FY2024)\u003c\/li\u003e\n\u003cli\u003eSCM software \u0026amp; logistics staff ~0.5-1% revenue\u003c\/li\u003e\n\u003cli\u003eGlobal rate volatility ±30% impacts margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmaintaining\u003e\u003c\/pglobal\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge 2024 cost mix: Raw materials 28% COGS, R\u0026amp;D 8-10%, SG\u0026amp;A 20-22%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGetinge's 2024 cost base: raw materials ~28% of COGS (Infection Control sales EUR 2.1bn), R\u0026amp;D ~8-10% revenue (≈SEK 1.7bn), SG\u0026amp;A ~20-22% (SEK 8.9bn), compliance SEK 300-450m, freight \u0026amp; insurance ~3-5% revenue (≈SEK 1.2-2.0bn), SCM\/IT ~0.5-1%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRaw materials\u003c\/td\u003e\n\u003ctd\u003e~28% COGS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e8-10% (~SEK 1.7bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e20-22% (SEK 8.9bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance\u003c\/td\u003e\n\u003ctd\u003eSEK 300-450m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFreight \u0026amp; insurance\u003c\/td\u003e\n\u003ctd\u003e3-5% (~SEK 1.2-2.0bn)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSCM\/IT\u003c\/td\u003e\n\u003ctd\u003e0.5-1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCapital Equipment Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa major portion of getinge revenue stems from one-time sales high-value capital equipment-surgical lights tables and sterilizers-accounting for roughly product revenues in with individual contracts often exceeding per hospital project. these cyclical underpin recurring service consumable streams-service consumables made up about group deals both spike cash flow seed long-term aftermarket income.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumables and Accessories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGetinge earns steady recurring revenue from single-use consumables and accessories-sterile filters, reprocessing detergents, and surgical disposables-tied to its installed base; consumables accounted for about 22% of Group sales in 2024 (~SEK 12.8bn), making the stream predictable and margin-accretive. As installed equipment grew ~3% in 2024, consumable sales rose ~5%, showing strong attach rates and predictable volume-linked growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService and Maintenance Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePost-sale service agreements deliver steady, high-margin revenue for Getinge AB (Sweden), covering preventive maintenance, repairs, and software updates for surgical and ICU equipment; service and consumables made up about 34% of Getinge's 2024 net sales (SEK 10.8bn of SEK 31.9bn), with gross margins typically 40-55%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware Licenses and Subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge now earns recurring revenue from software licenses and SaaS hospital-management tools-platforms for sterile-supply workflow and OR scheduling-reflecting a shift to digital health; software \u0026amp; digital sales accounted for about 8% of group sales in 2024, up from ~5% in 2021 (Getinge annual reports).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring SaaS fees increase ARR and margin stability\u003c\/li\u003e\n\u003cli\u003e8% of 2024 sales from software\/digital\u003c\/li\u003e\n\u003cli\u003eHospitals prioritize digitization, raising demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraining and Consulting Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGetinge sells specialized training and workflow consulting to hospitals, boosting staff efficiency and device utilization; in 2024 service contracts and professional services contributed about 14% of Getinge Group revenues, roughly SEK 5.6 billion.\u003c\/p\u003e\n\u003cp\u003eThese services increase hardware value and margin, reduce downtime, and create recurring professional-service income-client surveys show average utilization gains of 8-12% after consulting.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e14% of 2024 revenue (~SEK 5.6bn) from services\u003c\/li\u003e\n\u003cli\u003eTypical utilization uplift: 8-12%\u003c\/li\u003e\n\u003cli\u003eReduces downtime, lifts hardware ROI\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGetinge 2024: 45% Equipment, 34% Services \u0026amp; Consumables, 8% Software, 14% Professional\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpgetinge revenues split roughly: capital equipment service consumables software professional services overlaps percentages from getinge report\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eRevenue Stream\u003c\/th\u003e\n\u003cth\u003e2024 % of Sales\u003c\/th\u003e\n\u003cth\u003e2024 SEK (approx.)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapital equipment\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003ctd\u003e~SEK 14.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eService \u0026amp; consumables\u003c\/td\u003e\n\u003ctd\u003e34%\u003c\/td\u003e\n\u003ctd\u003e~SEK 10.8bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSoftware\/digital\u003c\/td\u003e\n\u003ctd\u003e8%\u003c\/td\u003e\n\u003ctd\u003e~SEK 2.6bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProfessional services\u003c\/td\u003e\n\u003ctd\u003e14%\u003c\/td\u003e\n\u003ctd\u003e~SEK 4.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pgetinge\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57347055747403,"sku":"getinge-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/getinge-canvas-business-model.webp?v=1779139370","url":"https:\/\/valuechainanalysis.com\/products\/getinge-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}